Edesa Biotech, Inc.EDSANASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -18.23% |
| Q3 2025 | -0.83% |
| Q2 2025 | 24.95% |
| Q1 2025 | -53.77% |
| Q4 2024 | -56.89% |
| Q3 2024 | -12.91% |
| Q2 2024 | 48.88% |
| Q1 2024 | -19.13% |
| Q4 2023 | 4.19% |
| Q3 2023 | 18.68% |
| Q2 2023 | -14.83% |
| Q1 2023 | 12.22% |
| Q4 2022 | 68.18% |
| Q3 2022 | -85.94% |
| Q2 2022 | -626.46% |
| Q1 2022 | 87.01% |
| Q4 2021 | -802.74% |
| Q3 2021 | 88.61% |
| Q2 2021 | 56.55% |
| Q1 2021 | -138.48% |
| Q4 2020 | -79.95% |
| Q3 2020 | -23.62% |
| Q2 2020 | -15.62% |
| Q1 2020 | -48.21% |
| Q4 2019 | 40.46% |
| Q3 2019 | 42.18% |
| Q2 2019 | -87.20% |
| Q1 2019 | 6.37% |
| Q4 2018 | -34.76% |
| Q3 2018 | 12.61% |
| Q2 2018 | 19.95% |
| Q1 2018 | -21.31% |
| Q4 2017 | -2.45% |
| Q3 2017 | -18.67% |
| Q2 2017 | 26.24% |
| Q1 2017 | 6.51% |
| Q4 2016 | -14.55% |
| Q3 2016 | -11.74% |
| Q2 2016 | 0.61% |
| Q1 2016 | 8.65% |